CompanyStageLast valuationTotal raised
SSonoThera, Inc.SonoThera develops gene therapies delivered by sonoporation, a microbubble-based method that temporarily opens cell membranes.Series CHealthcareLast valuationUndisclosedTotal raisedSign inSSouth Tees Healthcare Management LimitedUK private limited company incorporated 2016.Late stageHealthcareLast valuationUndisclosedTotal raised$0SSPINEOLOGY INCSpineology Inc., founded in 1997 in St. Paul, Minnesota, makes spinal implants, including the OptiMesh expandable interbody implant.Series AHealthcareLast valuationUndisclosedTotal raisedSign inSSPKL,LLCPrivate securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$135KS
StablepharmaUK biotechnology companyLate stageHealthcareLast valuationUndisclosedTotal raised$0SStemcell Technologies UK LTDUK private limited company incorporated 2014.Late stageHealthcareLast valuationUndisclosedTotal raised$0SStromaGenesis LLCPrivate securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$175KSSwep Bio, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$2.5MSSygnature Discovery LimitedUK private limited company incorporated 2004.Late stageHealthcareLast valuationUndisclosedTotal raised$0SSyncromune, Inc.Private securities offering disclosed via SEC Form D.Series CHealthcareLast valuationUndisclosedTotal raised$144.8MSSynthesis Med Chem (UK) LimitedUK private limited company incorporated 2011.Late stageHealthcareLast valuationUndisclosedTotal raised$0TTaurx Therapeutics Management LTD.UK private limited company incorporated 2016.Late stageHealthcareLast valuationUndisclosedTotal raised$0TTCM Life Science Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$16.7KTT-Cypher Bio Holdings LimitedUK private limited company incorporated 2020.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inTTelo Genomics Corp.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$7.3KTTempest Therapeutics, Inc.Tempest Therapeutics develops oral cancer therapies, led by Amezalpat (TPST-1120) for hepatocellular carcinoma.SeedHealthcareLast valuationUndisclosedTotal raisedSign inTTenNor Therapeutics (Suzhou) LtdPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$14.7MTTenpoint Therapeutics Holding LimitedUK private limited company incorporated 2024.Late stageActivities of other holding companies n.e.c.Last valuationUndisclosedTotal raised$0TTenpoint Therapeutics LimitedUK private limited company incorporated 2020.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inTTerremoto Biosciences, Inc.Terremoto Biosciences, Inc. develops drugs that covalently bind lysine, with lead AKT1-selective inhibitor programs.Series BHealthcareLast valuationUndisclosedTotal raisedSign inTTETmedical, Inc.Won a federal SBIR/STTR research award from HHS and other federal agencies.SeedHealthcareLast valuationUndisclosedTotal raised$3.5MTTetrous, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$1.7MTTheracryf PLCUK public limited company incorporated 2014.PublicHealthcareLast valuationUndisclosedTotal raised$0TTheradex (Europe) LimitedUK private limited company incorporated 1992.Late stageHealthcareLast valuationUndisclosedTotal raised$0TThinkBio.Ai, IncPrivate securities offering disclosed via SEC Form D.Series BHealthcareLast valuationUndisclosedTotal raised$20M